GNVR · Genvor Inc
$0.74
+0.43 (+138.48%)
At close · Aug 26
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern. ... Management's plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$26.94M
Shares
36.41M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Donald Kalkofen | Chief Financial Officer | Appointed | 2026-05-21 |
| Chad Pawlak, Sr. | Board of Directors | Appointed | 2024-11-13 |
| Judith S. Miller | member of the Board of Directors | Resigned | 2024-10-22 |
| Judith S. Miller | Chief Business Officer | Terminated | 2024-06-03 |
| Judith S. Miller | Interim Chief Financial Officer | Terminated | 2024-06-03 |
| Clayton Yates | scientific advisor | Appointed | 2024-01-23 |
| Clayton Yates | Chief Scientific Officer | Resigned | 2024-01-23 |
| Judith S. Miller | Interim Chief Financial Officer | Appointed | 2024-01-23 |
| Jesse Jaynes | Chief Scientific Officer | Appointed | 2024-01-23 |
| Judith S. Miller | Interim Chief Executive Officer | Resigned | 2024-01-23 |
| Judith S. Miller | member of the Company’s Board of Directors | Appointed | 2024-01-23 |
| Judith S. Miller | Chief Business Officer | Appointed | 2024-01-23 |
| Chad Pawlak | Chief Executive Officer | Appointed | 2024-01-23 |
| Judith S. Miller | Interim CEO | Appointed | 2023-10-10 |
| Judith S. Miller | Interim Chief Executive Officer | Appointed | 2023-07-06 |
| Bradley White | officer | Terminated | 2023-07-06 |
| Margaret McLaughlin | director | Resigned | 2021-02-01 |
| Margaret McLaughlin | officer | Resigned | 2021-02-01 |
| Robert Bubeck | officer | Resigned | 2021-02-01 |
| Jesse Jaynes | member of the Board | Appointed | 2021-02-01 |
| Robert Bubeck | director | Resigned | 2021-02-01 |
| Clayton Yates | Chief Scientific Officer | Appointed | 2021-02-01 |
| Jesse Jaynes | Chief Research Officer | Appointed | 2021-02-01 |
| Clayton Yates | member of the Board | Appointed | 2021-02-01 |
| Brad White | member of Allure's Board of Directors | Appointed | 2021-02-01 |